The enriched KEGG immune pathways included (Table 2) allograph rejection, antigen processing and presentation (S3 Fig), lymphocyte differentiation, immune cell activation, differentiation and development, MHC class two immune response and autoimmune diseases; type 1 diabetes, autoimmune thyroid disease and asthma. This evidence concerns the gene HLA-C and type 1 diabetes mellitus.